Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2003
05/14/2003EP1310495A2 Glycidyl amines and their use in the preparation of HIV protease inhibitors
05/14/2003EP1310485A1 Pyrrole derivatives
05/14/2003EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method
05/14/2003EP1309593A2 Substituted pyrazoles
05/14/2003EP1309587A1 Cinnoline compounds
05/14/2003EP1309586A1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders
05/14/2003EP1309585A2 Novel indole derivatives and their use as medicaments
05/14/2003EP1309569A2 Nitrogenous heterocyclic compounds
05/14/2003EP1309568A2 Nitrogenous heterocyclic compounds
05/14/2003EP1309567A2 Nitrogenous heterocyclic compounds
05/14/2003EP1309566A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/14/2003EP1309551A1 Indoline derivatives as 5ht2c antagonists
05/14/2003EP1309544A1 Compounds acting as melanocortin receptor ligands
05/14/2003EP1278743A4 Novel anti-infectives
05/14/2003EP1140935B1 1,2-annelated quinoline derivatives
05/14/2003EP1140905B1 Heteroaromatic amides as inhibitor of factor xa
05/14/2003EP1112266B1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
05/14/2003EP1109790B1 1, 2, 4-triazole-3-thione compounds
05/14/2003EP1045842B1 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
05/14/2003EP0999856B1 Radiopharmaceuticals for imaging infection and inflammation
05/14/2003EP0944617B1 Crystals of benzimidazole derivatives and their production
05/14/2003EP0934313B1 N-substituted azaheterocyclic compounds
05/14/2003EP0915869B1 Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/14/2003EP0816355B1 Heterocyclic spiro derivatives
05/14/2003CN1418199A Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418192A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof
05/14/2003CN1418188A Method for oxidizing thioether group into sulfoxide group
05/14/2003CN1418121A Compound with 5-HT1A activity useful for treating disorders of outer retina
05/14/2003CN1418100A Compounds with 5-HT activity useful for controlling visual field loss
05/14/2003CN1417209A Tetrahydroquinoline ketopiperidine compounds and their prepn and use
05/14/2003CN1108301C Inhibitors of microsomal triglyceride transfer protein and mothed
05/14/2003CN1108294C Piperazine-2,5-dione derivatives as modulators of multidrug resistance
05/14/2003CN1108293C Substituted 1-amino-3-phenyluracil derivatives, their preparation and their use as herbicides
05/14/2003CA2411691A1 New 2.5-diaminopyridine oxydation bases used to dye keratin fibres
05/13/2003US6562978 N-(3-(4-(4-(Aminocarbonyl)benzyl)-1-piperidinyl)propyl)-N-(3, 4-dichlorophenyl)-1-(methylsulfonyl)-4-piperidinecarboxamide or a salt thereof for treatment of AIDS
05/13/2003US6562977 For use in the synthesis of peptides and/or for the manufacture of pharmaceutically active substances or corresponding intermediates
05/13/2003US6562976 Such as methyl-2-cyclopentyl-4-(4-fluorophenyl)-5-oxo-7,7-dimethyl-1,4,5,6,7,8 -hexahydroquinoline-3-carboxylate for treatment of arteriosclerosis and dyslipidaemias; condensation
05/13/2003US6562967 Drug screening; purity
05/13/2003US6562966 Combining a racemic or a diastereomeric mixture of a chiral substrate with a nucleophile, in the presence of a chiral non-racemic catalyst
05/13/2003US6562964 Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders
05/13/2003US6562854 Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
05/13/2003US6562851 Antiinflammatory and antiasthmatic agents; inhibitors of alpha4 beta1 mediated cell adhesion
05/13/2003US6562847 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application
05/13/2003US6562846 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
05/13/2003US6562843 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders
05/13/2003US6562842 Osteoporosis, oral diseases
05/13/2003US6562839 6-substituted heteroquinolinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both
05/13/2003US6562831 Inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases
05/13/2003US6562828 Amidine compounds
05/13/2003US6562827 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562818 Irreversible inhibitors of tyrosine kinases
05/13/2003US6562817 Suppressants of the IgE production
05/13/2003US6562811 Pyridine derivatives
05/13/2003CA2261724C Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/13/2003CA2211681C Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
05/13/2003CA2202992C Heterocycle substituted propenoic acid derivatives as nmda antagonists
05/13/2003CA2127876C Imidazole derivatives and their use as cytokine inhibitors
05/13/2003CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment
05/13/2003CA2048980C 1-(pyridinylalkyl)-1h-indoles, indolines and related analogs
05/13/2003CA2021467C Heterocyclically substituted sulfonylureas, process for their preparation, and their use as herbicides or plant growth regulators
05/08/2003WO2003038123A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003WO2003037895A1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
05/08/2003WO2003037891A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003WO2003037890A2 Piperidines
05/08/2003WO2003037889A1 Compounds and method for the treatment of overactive bladder
05/08/2003WO2003037888A1 3-substituted-4-pyrimidone derivatives
05/08/2003WO2003037887A1 Therapeutic isoquinoline compounds
05/08/2003WO2003037886A2 Heteroaromatic carboxamide derivatives for the treatment of inflammation
05/08/2003WO2003037878A1 Substituted pyrimidines
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003WO2003037869A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003WO2003037866A1 Antiretroviral pyridine and quinoline derivatives
05/08/2003WO2003037865A1 Novel anticancer compounds
05/08/2003WO2003037864A1 Indole compound and medicinal use thereof
05/08/2003WO2003037863A2 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003WO2003037862A1 Amide derivatives and drugs
05/08/2003WO2003037861A1 Use of 2-acylindoles in the treatment of tumors
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037351A1 Heterocyclo-alkylsulfonyl pyrazoles and their use as cox-2 inhibitors
05/08/2003WO2003037349A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003WO2003037342A1 Method of treating depression with delta receptor agonist compounds
05/08/2003WO2003037341A1 Method for the treatment of overactive bladder
05/08/2003WO2003037338A2 Modulators of the cholesterol biosynthetic pathway
05/08/2003WO2003037336A1 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
05/08/2003WO2003037335A1 5-heteroatom-substituted pyrazoles
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/08/2003WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
05/08/2003WO2003037327A1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
05/08/2003WO2003037308A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003WO2003037274A2 Pyrazole-amides and-sulfonamides
1 ... 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 ... 1080